普洛藥業(000739.SZ):與中控技術簽訂戰略合作協議
格隆匯7月12日丨普洛藥業(000739.SZ)公佈,公司與浙江中控技術股份有限公司(“中控技術”)於近日簽署了《戰略合作伙伴協議書》,雙方就戰略採購、創新應用和資本合作等方面達成了深度戰略合作關係。
協議主要內容為在公司及其子公司的新建和改造項目中,為逐步實現自動化、數字化、智能化,中控技術提供全方位的資源支持,包括解決方案、產品、技術、服務等,響應公司需求;在合作期間,提供各種技術培訓,提高雙方技術人員的水平,開展文化交流活動,增進雙方的瞭解;後續根據國家政策,乙方協助甲方或共同進行政府項目申報工作,以爭取政府和社會的資源。
此次戰略合作是基於過去十多年雙方在多項目上的成功合作,可以更好地使用先進技術、產品和服務推動普洛藥業“四化”建設,提升企業運營效率,增強企業核心競爭力,對公司未來智能製造佈局具有非常重要的意義。同時,此次合作也可以整合雙方資源,發揮各自優勢,實現雙方更快更好的發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.